Cyborg | Designer-Babies | Futurism | Futurist | Immortality | Longevity | Nanotechnology | Post-Human | Singularity | Transhuman

Los Angeles, CA (PRWEB) April 19, 2014

MetroMD, Institute of Regenerative Medicine enunciates to offer laser skin resurfacing treatment to combat aging and deal with skin imperfections. Laser Skin treatment, alternatively known as DOT therapy is a new breakthrough in wellness industry. The revolutionary laser therapy is applied all over the face and neck to do away with frown lines, wrinkles, acne scars, unwanted folds, and sagging skin. The same laser is used to remove hyper pigmentation on the back of hands and tighten the loose, weathered skin along the forearms and thighs. The prominent institute in regenerative medicine industry runs a licensed Laser Skin Resurfacing Clinic Los Angeles. Source: Devin Stone, METROMD.

The breakthrough in the medical industry HGH, CO2 Fractional Laser, and Stem Cells are used together to combat the signs of aging, and overexposure to sunlight and to those who suffer from premature aging. Once administered the therapy increases blood flow, nearly vanishes the dark pigmented stains from UV rays,” says Dr. Alex Martin, Medical Director at the Institute. The skins appearance becomes healthy and rejuvenated within three weeks of the procedure. The unique amalgamation of FDA approved CO2 Laser, Human Growth Hormone and Stem Cell therapies work wonder on skin to make it radiant and youthful even after the age of forty. Over the last decade, many breakthroughs have occurred at the beginning of 21st Century to deal with the multitude of skin woes without having the need to undergo any conventional surgical techniques and longer rehabilitation period.

About MetroMD MetroMD is a Los Angeles based clinical institute and a leading provider of PRP, Stem Cell Therapy, Botox, Laser Skin Resurfacing and other innovative treatments. The institute treats the patients with latest technology to treat aging, improve sports performance, texture of hair, nail, libido enhancement with HGH therapy. All the treatments are FDA approved and hence considered safe. The institute runs licensed Stem Cell Therapy clinic in Los Angeles. HGH treatment is clinically proven to treat Human Growth Deficiency with excellent results.

MetroMD Institute of Regenerative Medicine 7080 Hollywood Blvd, Suite 804 Los Angeles, CA 90028 (323) 285-5300

See the article here:
Los Angeles Based Clinic MetroMD Expands Its Treatments of DOT Therapy, One of the Best Laser Skin Treatments for …

Regenerative Medicine, Younger skin, hair regrowth, PRP, stem cells, stretch marks
This presentation discuss using your own cells and platelets to regenerate your body for a healthier and younger you, whether it is for your face, neck, hand…

By: BangkokStemCells

Read the original here:
Regenerative Medicine, Younger skin, hair regrowth, PRP, stem cells, stretch marks – Video

Explore Personalized Medicine, with Sonia Arrison
Explore Personalized Medicine Sonia Arrison, Policy Analyst Author Examples of the kind of regenerative medicine that will ultimately eradicate cancer, AID…

By: Big Think Edge

Excerpt from:
Explore Personalized Medicine, with Sonia Arrison – Video

The Australian Regenerative Medicine Institute (ARMI) – Brazil
The Australian Regenerative Medicine Institute offers many opportunities for research.

By: MonashUniFMNHS

The Australian Regenerative Medicine Institute (ARMI) – Brazil – Video

The Australian Regenerative Medicine Institute (ARMI)
The Australian Regenerative Medicine Institute offers many opportunities for research.

By: MonashUniFMNHS

More here:
The Australian Regenerative Medicine Institute (ARMI) – Video

RANCHO CORDOVA, Calif. — Cesca Therapeutics Inc. , an autologous cell-based regenerative medicine company, today announced the restructuring of its sales, marketing and technical support organization …

View post:
Cesca Therapeutics Announces Sales & Marketing Organizational Restructuring and the Appointment of Industry Veteran …

Washington (PRWEB) April 15, 2014

Research that resulted in the first stem cells that are pluripotentthose that have the potential to differentiate into almost any cell in the bodywill be the backdrop for a discussion about trends in regulation in the field of regenerative medicine at the DIA 2014 50th Annual Meeting, June 15 to 19 in San Diego.

Chaired by Shinji Miyake, professor of clinical research for the Keio University School of Medicine in Japan, the session Pioneering Regenerative Medicine: Trends in Regulations for New Therapy will introduce the worlds first clinical research of induced pluripotent stem (iPS) cell products, conducted in Japan, and review updated regulatory guidance to bring regenerative medicine to patients who need healthy tissue or organs. The session will be held June 16 at 8:30 a.m. in the San Diego Convention Center.

iPS cells are stem cells that can be generated directly from adult cells. These cells can multiply indefinitely and represent a single source of cells, such as heart, neural, pancreatic and liver, that can be used to replace damaged cells.

In 2006, Japanese physician and researcher Shinya Yamanaka led a team to generate iPS cells from adult mouse tissue using gene therapy. This work led to a Nobel Prize in Physiology or Medicine in 2012 for the discovery that mature cells can be reprogrammed to become pluripotent.

We are honored to host pioneers of this unique field of medicine at the DIA Annual Meeting to share their experiences in the planning of the first clinical research of iPS cell productswhich have the ability to enhance research worldwide, said Barbara L. Kunz, DIA global chief executive. Their expert knowledge of issues and solutions in the application of the regenerative therapies will benefit all who advocate for and drive innovative medicine.

The session will also feature a presentation about the application of iPS cells to retinal diseases by Masayo Takahashi, project leader for the RIKEN Center for Developmental Biology in Japan, along with a European Medicines Agency (EMA) presentation by Dariusz Sladowski, researcher and member of the Committee for Advanced Therapies at EMA.

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIAs network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Pa., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit

ABOUT DIAs 2014 50th ANNUAL MEETING: Celebrate the Past Invent the Future is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development and life cycle management of medical products. The meeting aims to foster innovation that will lead to the development of safe and effective medical products and therapies for patients. For more information, visit

Continued here:
Pioneers in Regenerative Therapy to Discuss New Trends in Stem Cell Medicine

BURLINGTON, Mass., April 15, 2014 /PRNewswire/ –inVentiv Health Clinical, a leading global supplier of drug development services, announced today that it has been selected for an osteoarthritis Investigational New Drug Application (IND) by the innovative regenerative medicine biotechnology company IntelliCell BioSciences, Inc., (OTCQB:SVFC). IntelliCell will be studying the use of adult autologous vascular cells from blood vessels in adipose tissue to treat osteoarthritis of the knee.

The principal investigator is Dr. James Andrews, an orthopedic surgeon known internationally for his scientific and clinical research into knee, shoulder and elbow injuries. Dr. Andrews is a founding member of the American Sports Medicine Institute, author of numerous scientific articles and books and founding partner and medical director at the Andrews Institute in Gulf Breeze, Florida.

inVentiv Clinical will work with Dr. Andrews to develop investigational clinical study protocols and will serve as the Clinical Research Organization (CRO) on trials conducted at the Pensacola Center of the Andrews Institute.

IntelliCell’s technology for isolating stromal vascular fraction cells from the vasculature of adipose tissue has been used to treat more than 60 knees. IntelliCell’s Chief Executive Officer, Dr. Steven Victor, said this is what we believe will be the first of several clinical trials for the biotech company studying the use of its technology in treating a variety of diseases and conditions.

“inVentiv Clinical has extensive therapeutic experience in general pain and osteoarthritis programs and a focus on partnering with innovative bioscience companies,” said Raymond Hill, President of inVentiv Health Clinical. “We are looking forward to our work with Dr. Andrews and contributing to advances in the treatment of osteoarthritis in knees.”

inVentiv Health Clinical offers clients a full range of clinical research services supported by a global infrastructure, therapeutic expertise, and unmatched commitment to quality. For pharmaceutical, biotechnology, generic drug, and medical device companies, inVentiv conducts Phase I-III clinical trials, Phase IV late stage post-approval programs, as well as offering staffing, bioanalytical and regulatory services.

IntelliCell’s IND study will focus on proving the company’s patented technology of Ultrasonic Cavitation as a method of producing stromal vascular fraction cells as a new approach and improvement on current treatment which in the worst cases can involve surgery.

About 75% of people over 70 years of age show changes consistent with osteoarthritis and symptoms such as pain, joint stiffness and joint deformities. Osteoarthritis affects more than 25 million people in the United States alone.

Regenerative medicine is the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function by replacing damaged tissue and/or by stimulating the body’s own repair mechanisms to heal previously irreparable tissues or organs.

IntelliCell is planning an in-human clinical trial in late 2014 to study if the IntelliCell vascular fraction cells may demonstrate measurable benefits for patients suffering from this debilitating condition.

Read more:
inVentiv Health Clinical Engaged by IntelliCell Biosciences, a Regenerative Medicine Company, as Clinical Research …

3D Tissue Stimulation for Regenerative Medicine
See how a unique partnership between Loughborough University and Bose is advancing the field of tissue engineering and regenerative medicine.

By: ajf3015

Continue reading here:
3D Tissue Stimulation for Regenerative Medicine – Video

Custom Compounding and Regenerative Medicine – The Kohana Difference

By: KohanaRx

Visit link:
Custom Compounding and Regenerative Medicine – The Kohana Difference – Video

iPSCs for cardiovascular diseases
This video highlights application of pluripotent stem cells for cardiac disease modeling, drug discovery, and regenerative medicine.

By: StanfordUniversity

Follow this link:
iPSCs for cardiovascular diseases – Video

USC Master of Science in Stem Cell Biology and Regenerative Medicine
The Master of Science degree program is the first in stem cell biology and regenerative medicine in California, and one of only three in the U.S. The one-yea…

By: USCKeck

The rest is here:
USC Master of Science in Stem Cell Biology and Regenerative Medicine – Video

IntelliCell BioSciences, Inc. , a regenerative medicine company utilizing adult autologous stomovascular cells derived from the blood vessels found in adipose tissue, announced today that it has engaged …

See the article here:
IntelliCell BioSciences Has Engaged inVentiv Clinical as CRO for Osteoarthritis IND Lead by Dr. James Andrews

Professor Alexander Seifalian

There aren’t many scientists who have grown human cells on the back of a butterfly wing, but Alexander is one of them!

Professor Alexander Seifalian (UCL Centre for Nanotechnology & Regenerative Medicine) and his team are aiming to make organ donation a thing of the past, combining nano-composite materials with stem cell technologies for the growth of replacement organs.

He used his discoveries to fight for the life of a young Icelandic man whose throat was destroyed by cancer. Given two weeks to live, Alexander set out to build for the man the world’s first artificial windpipe, made from nanomaterials and stem cells – and succeeded.

“Welcome to the body parts shop… would you like to place an order?”

Excerpt from:
Welcome to the body parts shop… would you like to place an order?

Sarasota, Florida (PRWEB) April 12, 2014

Jonathan Greco, MD will speak on the subject of regenerative medicine on Monday, April 14th at the Savannah Grand Senior Community in Sarasota, Florida. Dr. Greco is a leading physician in Regenerative Medicine, a rapidly growing field that offers alternatives to invasive surgeries. Titled “Keeping Your Own Hardware – Alternatives to Joint Replacement” the presentation will begin at 11:30 a.m. and include a question and answer session, and there is no charge.

Every day there are breakthroughs in the science of regenerative medicine, which is really exciting and promising for patients who are in pain, said Dr. Greco. Surgery is always an option, but we are trying to restore health through these new technologies, which involve far less stress and strain on the body.

Advances in PRP (Platelet Rich Plasma) and CRP (C-Reactive Protein) therapies are offering realistic and effective treatments that can actually repair damage to joints from normal aging and injuries.

Dr. Greco graduated from the Pennsylvania State University and Drexel University School of Medicine with advanced work at the Medical College of Pennsylvania Hospital and the Philadelphia Veteran’s Administration Hospital. Certifications include American Board of Clinical Lipidology, American Board of Internal Medicine, and the National Board of Medical Examiners. Licensed in Florida and Pennsylvania, Dr. Greco has numerous published cases and research papers and is nationally renowned in regenerative medicine.

The Savannah Grand of Sarasota is located at 7130 Beneva Road | Sarasota, FL 34238 | Phone: 941-404-1473.

Dr. Grecos office is located at 1990 Main Street, | Suite 700 | Sarasota, FL 34236 | Phone 941-952-3300 |

Visit link:
Regenerative Medicine Specialist to Speak on Alternatives to Joint Replacement

WINSTON-SALEM, N.C. Doctors at the Wake Forest Institute for Regenerative Medicine have successfully grown and implanted vaginas into four young women.

The women, 13-18 years old, all have a condition known as Mayer-Rokitansky-Kster-Hauser syndrome, which causes the vaginal organ to be underdeveloped or absent. The success of the study was recently published in The Lancet.

The team obtained a vulvar tissue biopsy from each patient from which they grew smooth muscle cells and vaginal epithelial cells in the lab. The cells were then placed onto specially designed vagina-shaped biodegradeable scaffolds and left to grow for 7 days. The researchers then surgically implanted the engineered vaginas, which remain structurally and functionally normal 8 years on, according to a news release from The Lancet.

Doctor Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine, led the research team.

This pilot study is the first to demonstrate that vaginal organs can be constructed in the lab and used successfully in humans, said Atala. This may represent a new option for patients who require vaginal reconstructive surgeries. In addition, this study is one more example of how regenerative medicine strategies can be applied to a variety of tissues and organs.

Atala says half of women diagnosed with MRKH syndrome are unable to become pregnant. He says two of the women who participated in the clinical study are able to have children. However, the women have not gotten pregnant yet, so doctors do not know if natural child birth will be possible.

Read more from the original source:
Doctors successfully implant lab-grown vaginas in four women

Anti Aging Regenerative Medicine Orlando Fl Maria Patricia llagan, We are your Integrative, Anti-Aging Medical Office in Orlando Florida. Call Us Today at (407) 674-9137 or Visit: Whole Fam…

By: Whole Family Healthcare

View original post here:
Anti Aging Regenerative Medicine Orlando Fl Maria Patricia llagan – Video

VistaGen Therapeutics, Inc. , a biotechnology company applying pluripotent stem cell technology for drug rescue and regenerative medicine, today announced that it has become a member of the Cardiac Safety …

Read the original:
VistaGen Joins the Cardiac Safety Research Consortium

It may not be to quite the same level achieved by Victor Frankenstein, but work by a team from the University of Edinburgh is likely to have significant real-world implications in the field of regenerative medicine. For the first time, the team has successfully regenerated a living organ in mice, not by using a jolt of electricity, but by manipulating DNA.

The organ in question was the thymus, which is located next to the heart and is an integral part of the immune system. In humans, it achieves most of its growth in early life, continuing to then grow slowly until puberty when it slowly begins to shrink for the remainder of a person’s life. It’s deterioration with age leaves older people with greater susceptibility to infections, such as flu.

In a study led by researchers from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh, levels of a protein called FOXN1, which is produced by cells of the thymus and helps control how important genes are switched on and off, was increased. This instructed the stem cell-like cells to rebuild the organ in very old mice.

This resulted in the thymus being regenerated to have a similar structure to those found in a young mouse, with the organ’s function restored and the mice producing more white blood cells called T cells, which play a central role in fighting infection.

The breakthrough could lead to new therapies for the treatment of people with damaged immune systems and genetic conditions that affect thymus development, such as DiGeorge syndrome. However, the team says more work will need to be done to ensure the process can be tightly controlled before the approach is tested on humans.

“One of the key goals in regenerative medicine is harnessing the bodys own repair mechanisms and manipulating these in a controlled way to treat disease,” says Dr Rob Buckle, the Head of Regenerative Medicine at the MRC. “This interesting study suggests that organ regeneration in a mammal can be directed by manipulation of a single protein, which is likely to have broad implications for other areas of regenerative biology.”

The team’s study is published in the journal Development.

Source: University of Edinburgh

Read the rest here:
World-first regeneration of a living organ

Contact Information

Available for logged-in reporters only

Newswise NEW YORK, NY (April 9, 2014) Dr. Mahendra Rao, who has directed the Center for Regenerative Medicine at the National Institutes of Health (NIH CRM) since 2010, will join The New York Stem Cell Foundation (NYSCF) Research Institute as its Vice President for Regenerative Medicine, a newly created position, Susan Solomon, NYSCF Chief Executive Officer, announced today.

Dr. Rao, who holds an MD degree and a PhD in developmental neurobiology, is one of the nations most prominent stem cell scientists. He has over twenty years of experience in all aspects of the stem cell field including government, academia, and business. Before joining the NIH, Dr. Rao spent six years as the vice president of Regenerative Medicine at Life Technologies, Inc. (now Thermo Fisher Scientific) after serving as the chief of Neurosciences at the National Institute on Aging and co-founding Q Therapeutics, a neural stem cell company based in Utah. Dr. Rao is tenured at the University of Utah School of Medicine in both Neurobiology and Anatomy and has over twenty submitted and ten issued patents.

Dr. Raos expertise in translational research, academia, and industry make him a valuable asset in our mission to take stem cell research from the laboratory to the clinic in order to find cures for the diseases that affect those we love, Solomon said. We are delighted to have him on board.

Solomon said that recruiting Dr. Rao is a major coup for NYSCF as it builds on its existing successes and carries out its strategic goals. Dr. Raos expertise and experience in setting up a company and in leading the translational effort at NIH will complement their expertise in automation and high-throughput induced pluripotent stem (iPS) cell generation.

I am enthused about NYSCFs efforts to generate high-quality stem cell lines and partner with the pharma and academic communities. I am excited to be joining them to advance their goals, said Dr. Rao.

In addition to his business career, Dr. Rao has served on scientific advisory boards, editorial boards and review panels and on committees including as the U.S. Food and Drug Administrations Cellular, Tissue, and Gene Therapies Advisory Committee chair and as the California Institute of Regenerative Medicine and International Society for Stem Cell Research liaison to the International Society for Cellular Therapy. Currently, he sits on the board of Cesca Therapeutics, Inc. and serves as the Chief Strategy Officer and Chairman of the Scientific Advisory Board at Q Therapeutics.

“Mahendra is a widely-recognized and accomplished leader in stem cell research. He will be a major asset for NYSCF as we continue to develop new therapeutics for patients,” said Dr. Zach Hall, NYSCF Board Member and former Director of National Institute of Neurological Disorders and Stroke.

About The New York Stem Cell Foundation

The rest is here:
Mahendra Rao Joins The New York Stem Cell Foundation Research Institute

FireFox! Start Your Own Web Hosting Company
Web Hosting Advertise Here $10 a Month Affordable web-hosting
Pierre Teilhard De Chardin

Designer Children | Prometheism | Euvolution | Transhumanism

Sign up below for the Prometheism / Designer Children Discussion Forum

Subscribe to prometheism-pgroup

Powered by